PeptideDB

NSC 13138 (Cinchoninic acid (6CI,7CI,8CI); 4-Carboxyquinoline) 486-74-8

NSC 13138 (Cinchoninic acid (6CI,7CI,8CI); 4-Carboxyquinoline) 486-74-8

CAS No.: 486-74-8

NSC 13138 is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NSC 13138 is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C10H7NO2
Molecular Weight 173.17
Exact Mass 173.047
CAS # 486-74-8
PubChem CID 10243
Appearance White to off-white solid powder
Density 1.3±0.1 g/cm3
Boiling Point 348.7±15.0 °C at 760 mmHg
Melting Point 254-255 °C(lit.)
Flash Point 164.7±20.4 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.685
LogP 1.99
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 13
Complexity 205
Defined Atom Stereocenter Count 0
InChi Key VQMSRUREDGBWKT-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H7NO2/c12-10(13)8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H,12,13)
Chemical Name

quinoline-4-carboxylic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation Quinoline-4-carboxylic acid is a quinolinemonocarboxylic acid. It is a conjugate acid of a quinoline-4-carboxylate.
Quinoline-4-carboxylic acid has been reported in Archangium with data available.
See also: Quinoline-4-carboxylate (annotation moved to).

Solubility Data


Solubility (In Vitro) DMSO: 50 mg/mL (288.73 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (14.44 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (14.44 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (14.44 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.7747 mL 28.8734 mL 57.7467 mL
5 mM 1.1549 mL 5.7747 mL 11.5493 mL
10 mM 0.5775 mL 2.8873 mL 5.7747 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.